Royal Bank of Canada Raises IDEAYA Biosciences (NASDAQ:IDYA) Price Target to $61.00
IDEAYA Biosciences (NASDAQ:IDYA – Free Report) had its price objective raised by Royal Bank of Canada from $53.00 to $61.00 in a research note issued to investors on Thursday, Benzinga reports. They currently have an outperform rating on the stock. Other equities analysts have also issued reports about the stock. Mizuho assumed coverage on shares […]
More Stories
iShares Ultra Short-Term Bond Active ETF (BATS:ICSH) Sets New 1-Year High – What’s Next?
Shares of iShares Ultra Short-Term Bond Active ETF (BATS:ICSH – Get Free Report) hit a new 52-week high on Thursday...
Short Interest in Pioneer Floating Rate Fund, Inc. (NYSE:PHD) Decreases By 25.5%
Pioneer Floating Rate Fund, Inc. (NYSE:PHD – Get Free Report) was the target of a significant decrease in short interest...
iShares iBoxx $ High Yield Corporate Bond ETF Sees Unusually Large Options Volume (NYSEARCA:HYG)
iShares iBoxx $ High Yield Corporate Bond ETF (NYSEARCA:HYG – Get Free Report) was the recipient of unusually large options...
Arhaus (NASDAQ:ARHS) Rating Increased to Outperform at Telsey Advisory Group
Arhaus (NASDAQ:ARHS – Get Free Report) was upgraded by analysts at Telsey Advisory Group from a “market perform” rating to...
Microsoft (NASDAQ:MSFT) Trading Up 0.4% – Time to Buy?
Shares of Microsoft Co. (NASDAQ:MSFT – Get Free Report) were up 0.4% during mid-day trading on Tuesday . The company...
Sprinklr (NYSE:CXM) Stock Price Down 1.1% – What’s Next?
Sprinklr, Inc. (NYSE:CXM – Get Free Report) shares fell 1.1% during trading on Tuesday . The company traded as low...